一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Degarelix

Degarelix  Struktur
214766-78-6
CAS-Nr.
214766-78-6
Englisch Name:
Degarelix
Synonyma:
Degarelix acetate;FirMagon;Dikarek;DEGARELIX;Degarelix-d7;Peptides Acetate;Degarelix impurity;DEGARELIX USP/EP/BP;Degarelix acetate salt;Degarelix, Degarelix acetate
CBNumber:
CB52448443
Summenformel:
C82H103ClN18O16
Molgewicht:
1632.26
MOL-Datei:
214766-78-6.mol

Degarelix Eigenschaften

Dichte
1.325±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
L?slichkeit
DMSO:10.0(Max Conc. mg/mL);6.13(Max Conc. mM)
H2O:25.0(Max Conc. mg/mL);15.32(Max Conc. mM)
pka
10.38±0.40(Predicted)
Aggregatzustand
Solid
Farbe
White to off-white
Sequenz
Ac-D-2-Nal-D-4-Cl-Phe-D-3-Pal-Ser-4-Aph(Hor)-4-D-Aph(Cbm)-Leu-Lys(ipr)-Pro-D-Ala-NH2
InChIKey
MEUCPCLKGZSHTA-XYAYPHGZSA-N
Sicherheit
  • Risiko- und Sicherheitserkl?rung
  • Gefahreninformationscode (GHS)
Bildanzeige (GHS) Health Hazard (GHS08)
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H360 Kann die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. Fertility (Fruchtbarkeit) Kategorie 1 Achtung
Sicherheit

Degarelix Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Antagonists of GnRH have proven to be an effective therapy for hormonally regulated cancers, such as prostate and some types of breast. As analogs of GnRH, they bind competitively and reversibly to GnRH receptors in the pituitary gland, thereby blocking the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In men, the reduction of LH triggers the ablation of testosterone secretion from the testes, and these castration-like levels have been essential in the effective management of advanced prostate cancer. In comparison to GnRH agonists, antagonists do not suffer from a potential flare of the disease as a result of an initial stimulation of the hypothalamic-pituitary-gonadal axis prior to down-regulation of the GnRH receptor. Moreover, GnRH antagonists provide beneficial effects more rapidly postdosing and result in a more efficient suppression of gonadotropin levels. With this in mind, degarelix acetate has been launched as a third-generation GnRH antagonist for the treatment of prostate cancer, and it joins other third-generation agents, ganirelix and cetronelix, on the market.

Verwenden

Degarelix, is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist.

Clinical Use

Ferring launched degarelix acetate, a gonadotrophin-releasing hormone (GnRH) antagonist, in 2009 in the U.S. for the treatment of prostate cancer. The compound has been approved by the E.U. for the same indication, and in the same year it was launched in the UK and Germany. Degarelix has been developed as a one-month or three-month sustained-release injectable formulation. Compared to other GnRH antagonists, degarelix displays improved aqueous solubility, longer acting effects and weaker histamine-releasing properties.

Nebenwirkungen

The most common adverse events included injection site reactions (pain, erythema, swelling, or induration), hot flashes, increased weight, and increases in serum levels of transaminases and gamma-glutamyltransferase. In addition to being contraindicated in patients with a previous hypersensitivity to degarelix, it should not be administered to women who are or may become pregnant as fetal harm can occur. Since long-term androgen deprivation therapy prolongs the QT interval, physicians should consider whether the benefits of degarelix outweigh the potential risks in patients with congenital long QT syndrome, electrolyte abnormalities, or congestive heart failure or in patients taking antiarrhythmic medications.

Degarelix Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Degarelix Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 278)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
AFINE CHEMICALS LIMITED
+86-571-85134551
info@afinechem.com China 15083 58
Apextide Co Ltd
+8615300650552
info@apextide.com China 91 58
Chengdu Shengnuo Biopharm Co.,Ltd
+8613880038419
leili@snbiopharm.com China 70 58
RongNa Biotechnology Co.,Ltd
+86-86-13583358881 +8618560316533
Brad@rongnabiotech.com China 3366 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971
deasea125996@gmail.com China 2472 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 973 58
Nantong Guangyuan Chemicl Co,Ltd
+undefined17712220823
admin@guyunchem.com China 615 58
Chongqing Soarwin Technology Co., Ltd
+86-15790943001
crystal@sorawin.cn China 421 58
Xi an Biohorlden Industry Trade Co Ltd
+86-18829283179 +86-13636819721
sales@horlden.com China 334 58
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
+86-15225627621 +86-13213167925
jiuyitime@fdachem.com China 16512 58

214766-78-6()Verwandte Suche:


  • DEGARELIX
  • N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-4-[2,6-dioxohexahydropyrimidin-4(S)-ylcarboxamido]-L-phenylalanyl-4-ureido-D-phenylalanyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide acetate
  • D-Alaninamide, N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
  • Degarelix acetate(FE-200486,Degarelix)
  • Degarelix, Degarelix acetate
  • Degarelix acetate salt
  • D-Alaninamide,N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-ly
  • D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
  • Degarelix impurity
  • DEGARELIX USP/EP/BP
  • Degarelix-d7
  • Dikarek
  • Peptides Acetate
  • D7-Degarelix Trifluoroacetate
  • FirMagon
  • Degarelix acetate
  • 214766-78-6
  • 217466-78-6
  • C82H103ClN18O16C2H4O2
  • C82H103N18O16Cl
  • C82H103ClN18O16
  • API
Copyright 2019 ? ChemicalBook. All rights reserved
历史| 温宿县| 奉节县| 吴旗县| 弥渡县| 精河县| 铜陵市| 白朗县| 甘洛县| 乌兰浩特市| 灵武市| 双城市| 襄樊市| 古蔺县| 榆树市| 北海市| 垫江县| 南华县| 绥中县| 崇明县| 马关县| 竹溪县| 同仁县| 昌黎县| 关岭| 龙海市| 榆中县| 建宁县| 通山县| 家居| 香格里拉县| 石景山区| 江北区| 长治县| 隆安县| 金湖县| 蒲城县| 巨鹿县| 西平县| 静安区| 砚山县|